Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wahl, A.
Right arrow Articles by Windecker, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wahl, A.
Right arrow Articles by Windecker, S.
Related Collections
Right arrow All Cerebrovascular disease/Stroke
Right arrow Cardiac
Right arrow Embolism
Neurology 2001;57:1330-1332
© 2001 American Academy of Neurology
Brief Communications

Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism

A. Wahl, MD, B. Meier, MD, B. Haxel, MD, K. Nedeltchev, MD, M. Arnold, MD, E. Eicher, MD, M. Sturzenegger, MD, C. Seiler, MD, H. P. Mattle, MD and S. Windecker, MD

From the Departments of Cardiology (Drs. Wahl, Meier, Seiler, and Windecker), and Neurology (Drs. Nedeltchev, Arnold, Eicher, Sturzenegger, and Mattle), University Hospital Bern, Switzerland.

Address correspondence and reprint requests to Dr. Stephan Windecker, Cardiology, Swiss Cardiovascular Center Bern, University Hospital, CH-3010 Bern, Switzerland; e-mail: stephan.windecker{at}insel.ch

The long-term risk and risk factors for recurrent embolism after percutaneous closure of patent foramen ovale (PFO) were investigated in 152 consecutive patients with presumed paradoxical embolism. During follow-up, the actuarial freedom from recurrent embolism was 95.1% at 1 year, and 90.6% at 2 and 6 years. A residual shunt after percutaneous PFO closure was a predictor for recurrence (RR 5.3; 95% CI 1.3 to 21.0; p = 0.02). Randomized trials comparing medical treatment with percutaneous PFO closure in the prevention of recurrent embolism are in progress.




This article has been cited by other articles:


Home page
 J Am Coll Cardiol IntvHome page
D. R. Holmes Jr, R. Nishimura, R. Fountain, and Z. G. Turi
Iatrogenic Pericardial Effusion and Tamponade in the Percutaneous Intracardiac Intervention Era
J. Am. Coll. Cardiol. Intv., August 1, 2009; 2(8): 705 - 717.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
A. Wahl, T. Tai, F. Praz, M. Schwerzmann, C. Seiler, K. Nedeltchev, S. Windecker, H. P. Mattle, and B. Meier
Late Results After Percutaneous Closure of Patent Foramen Ovale for Secondary Prevention of Paradoxical Embolism Using the Amplatzer PFO Occluder Without Intraprocedural Echocardiography: Effect of Device Size
J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 116 - 123.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
P. Sorajja and R. A. Nishimura
Patent Foramen Ovale Closure Without Echocardiography: Are We Closing the Door Too Fast Too Soon?
J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 124 - 126.
[Full Text] [PDF]

Home page
 HeartHome page
A Wahl and B Meier
Patent foramen ovale and ventricular septal defect closure
Heart, January 1, 2009; 95(1): 70 - 82.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Windecker and B. Meier
Patent Foramen Ovale and Cryptogenic Stroke: To Close or Not to Close? Closure: What Else!
Circulation, November 4, 2008; 118(19): 1989 - 1997.
[Full Text] [PDF]

Home page
 HeartHome page
A Wahl, M Kunz, A Moschovitis, T Nageh, M Schwerzmann, C Seiler, H P Mattle, S Windecker, and B Meier
Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism
Heart, March 1, 2008; 94(3): 336 - 341.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Handke, A. Harloff, M. Olschewski, A. Hetzel, and A. Geibel
Patent Foramen Ovale and Cryptogenic Stroke in Older Patients
N. Engl. J. Med., November 29, 2007; 357(22): 2262 - 2268.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
B. M. MacKnight, J. D. Stearns, L. A. Vricella, and J. R. Resar
Migration of an Embolized Patent Foramen Ovale Closure Device to the Left Ventricular Outflow Tract
Anesth. Analg., November 1, 2007; 105(5): 1229 - 1230.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. R. Di Tullio, R. L. Sacco, R. R. Sciacca, Z. Jin, and S. Homma
Patent Foramen Ovale and the Risk of Ischemic Stroke in a Multiethnic Population
J. Am. Coll. Cardiol., February 20, 2007; 49(7): 797 - 802.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
E. Bedard, J. Rodes-Cabau, C. Houde, A. Mackey, D. Rivest, S. Cloutier, M. Noel, A. Marrero, J.-M. Cote, P. Chetaille, et al.
Enhanced Thrombogenesis but Not Platelet Activation Is Associated With Transcatheter Closure of Patent Foramen Ovale in Patients With Cryptogenic Stroke
Stroke, January 1, 2007; 38(1): 100 - 104.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
C. Spies, R. Strasheim, I. Timmermanns, and R. Schraeder
Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder
Eur. Heart J., February 1, 2006; 27(3): 365 - 371.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Homma and R. L. Sacco
Patent Foramen Ovale and Stroke
Circulation, August 16, 2005; 112(7): 1063 - 1072.
[Full Text] [PDF]

Home page
 StrokeHome page
G.P. Anzola, E. Morandi, F. Casilli, and E. Onorato
Does Transcatheter Closure of Patent Foramen Ovale Really "Shut the Door?": A Prospective Study With Transcranial Doppler
Stroke, September 1, 2004; 35(9): 2140 - 2144.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Windecker, A. Wahl, K. Nedeltchev, M. Arnold, M. Schwerzmann, C. Seiler, H. P. Mattle, and B. Meier
Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke
J. Am. Coll. Cardiol., August 18, 2004; 44(4): 750 - 758.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M Braun, V Gliech, A Boscheri, S Schoen, G Gahn, H Reichmann, M Haass, R Schraeder, and R.H Strasser
Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: Periprocedural safety and mid-term follow-up results of three different device occluder systems
Eur. Heart J., March 1, 2004; 25(5): 424 - 430.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
M Schwerzmann, S Windecker, A Wahl, H Mehta, K Nedeltchev, H Mattle, C Seiler, and B Meier
Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy
Heart, February 1, 2004; 90(2): 186 - 190.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
P. Khairy, C. P. O'Donnell, and M. J. Landzberg
Transcatheter Closure versus Medical Therapy of Patent Foramen Ovale and Presumed Paradoxical Thromboemboli: A Systematic Review
Ann Intern Med, November 4, 2003; 139(9): 753 - 760.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
J. Borgermann, K. Hakim, I. Friedrich, and C. Diez
Recurrent thromboembolic events after percutaneous device closure of patent foramen ovale
Interactive CardioVascular and Thoracic Surgery, June 1, 2003; 2(2): 125 - 127.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
B. Meier and J. E. Lock
Contemporary Management of Patent Foramen Ovale
Circulation, January 7, 2003; 107(1): 5 - 9.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.